Titan Pharmaceuticals, Inc. Operating Lease Liability
Titan Pharmaceuticals, Inc. had Operating Lease Liability of $33.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-05-15
- 2024-03-31: Operating Lease, Liability $33.00K.
- 2023-12-31: Operating Lease, Liability $65.00K.
- 2023-09-30: Operating Lease, Liability $97.00K.
- 2023-06-30: Operating Lease, Liability $128.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-03-31 | $33.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $65.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $97.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $128.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $158.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $187.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $216.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $245.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $272.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $299.00K 10-K · filed 2022-03-25 |
| 2021-09-30 | $325.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $352.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $76.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $150.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $222.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $292.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $358.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $422.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | $484.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $545.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $600.00K 10-Q · filed 2019-05-15 |